Associate Director, Analytical Development and Quality Control

At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions. We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team. What You’ll Do: The Associate Director, Analytical Development and Quality Control will support analytical development and Quality Control operations for clinical development and commercialization of Kailera’s pipeline compounds. The individual will provide technical expertise and will work closely with cross-functional stakeholders to ensure end-to-end drug development and manufacturing activities are executed seamlessly and in alignment with the company’s integrated development plans and program timelines. Required location: Waltham, MA (hub-based, onsite 3-4 days per week) Responsibilities: Support analytical development and QC activities related to characterization of drug substances and drug products from early-stage clinical development through commercialization Maintain current knowledge in analytical methods and control strategies supporting a variety of molecule platforms and dosage forms Oversee and provide scientific leadership on QC testing for DS/DP at vendors, ensuring cGMP compliance, data integrity, and timely delivery of analytical results Direct investigations including OOS/OOT, deviations, and CAPAs, and provide strong analytical rationale Design and manage stability programs (accelerated, long-term, bracketing/matrixing) supporting early and late clinical phases Interpret stability trends and establish shelf-life/retest periods consistent with ICH guidelines and peptide behavior Support comparability assessments for process changes, analytical method updates, or site transfers Communicate CMC project status to key stakeholders cross-functionally and assist in driving decision-making Participate in cross-functional CMC teams for the project(s) assigned to ensure adequate development and execution of CMC plan/strategies as needed Author and review CMC sections of IND/IMPD and NDA submissions and address regulatory questions Prepare for audits/inspections and represent analytical and QC functions to regulatory authorities Lead, mentor, and develop analytical and QC staff while driving continuous improvement and phase-appropriate analytical strategies Required Qualifications: 10+ years of experience, or 5+ with advanced degree, in the pharmaceutical/biotech industry with experience in all phases of innovative drug development and commercial launch in accordance with global CMC regulatory filings (IND/NDA/MAA, etc.) Strong expertise in analytical techniques HPLC/UPLC, LC–MS, SE-HPLC, dissolution, along with extractables and leachable analysis Knowledge of drug development activities with respect to cGMP, quality systems, ICH guidelines, global regulatory requirements, and USP, EP, JP, and CHP requirements Hands-on experience supporting early- and late-stage CMC development, stability programs, and specification setting Proven experience leading OOS/OOT investigations, deviations, CAPAs, and change controls Strong track record of working with CROs/CMOs and managing external analytical/testing activities Excellent technical writing skills for analytical reports and regulatory submissions (IND/IMPD, NDA/BLA) Demonstrated leadership ability with experience mentoring and developing scientific staff Strong communication, cross-functional collaboration, and project-management skills Innovative team-player with high energy for our dynamic company environment Preferred Qualifications: Prior peptide p ... (truncated, view full listing at source)